Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Theriva Biologics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 17 | 1 | 20 | +4 |
| Shares | 291.0K | 100 | 437.1K | +146.1K (+50.2%) |
| Value | $126.3K | $43 | $177.0K | +$50.8K (+40.2%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Theriva Biologics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 61,837 | $25.1K | 0.00% |
| Jane Street Group, LLC | 36,771 | $14.9K | 0.00% |
| Two Sigma Advisers, LP | 27,284 | $11.1K | 0.00% |
| Vanguard Group Inc | 16,382 | $6.63K | 0.00% |
| HRT Financial LP | 10,142 | $4.00K | 0.00% |
| Clear Street Group Inc. | 100 | $41 | 0.00% |
| Wealthspire Advisors, LLC | 2 | $1 | 0.00% |
| Citigroup Inc | 1 | $0 | 0.00% |
Sold out (4)
Institutions that held Theriva Biologics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 36,018 | $15.6K |
| Two Sigma Securities, LLC | 17,818 | $7.73K |
| FMR LLC | 3,000 | $1.30K |
| Pandora Wealth, Inc. | 4 | $2 |
Not filed for Q3 2025 yet (1)
Institutions that held Theriva Biologics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 100 | $43 |